Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  Concord Medical Starts $150 Million Healthcare Fund with Partner
  Cui Yutao Pediatric Online App and Clinic Completes $20 Million C Round
  Sequoia Makes $30+ Million Investment in China Cardiac Hospital Chain
  Beijing's Bioyong Forms $38 Million IVD Collaboration with Biodesix
  German Merck to Open Biologic CRO/CMO Centers in Shanghai and Boston
  Chi-Med Starts China Phase I Trial of Syk Inhibitor
  China's Sanpower Acquires Dendreon for $820 Million
  Fosun Forms $95 Million China CAR-T JV with Kite Pharma
  AbbVie, GMI, WuXi NextCODE Form Alliance to Sequence 45,000 Irish Genomes
  Alphamab/3DMed Announce China Approval for PD-L1 Antibody Trial
 
Login